CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
drugs in a regimen called FOLFIRINOX, to patients who have pancreatic cancer which has metastasised (spread). The study is being ru...
Phase 1, Phase 2
Cleveland, Ohio, United States and 5 other locations
of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The...
Cleveland, Ohio, United States and 2 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Cleveland, Ohio, United States and 108 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Cleveland, Ohio, United States and 76 other locations
This study is open to adults with advanced pancreatic cancer. The study tests a type of immunotherapy. It is a protein treatment co...
Phase 1
Cleveland, Ohio, United States and 24 other locations
(PK) and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in participants with advanced solid tumors...
Phase 1
Cleveland, Ohio, United States and 15 other locations
advanced cancers having a specific KRAS mutation will be included.In Part B (Phase 2), participants will be assigned to receive one of up t...
Phase 1, Phase 2
Cleveland, Ohio, United States and 13 other locations
The goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the s...
Phase 1, Phase 2
Cleveland, Ohio, United States and 12 other locations
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Cleveland, Ohio, United States and 57 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Cleveland, Ohio, United States and 124 other locations
Clinical trials
Research sites
Resources
Legal